Author

Evanthia Zampeli 1

1 Gastroenterology, Alexandra Hospital, Athens, Greece

2ND LINE LEVOFLOXACIN-BASED TRIPLE THERAPIES PROVIDE SIMILAR HELICOBACTER PYLORI ERADICATION RATES TO BISMUTH-BASED QUADRUPLE THERAPIES.

Spyridon Michopoulos, Evanthia Zampeli, Konstantinos Argyriou, Vasileios Xourafas, Iordanis Kisouras, Helias Kourkoutas, Beatriz Martinez-Gonzalaz, Dionyssios Sgouras, Andreas Mentis

HEPATOBILIARY, PANCREATIC AND RENAL MANIFESTATIONS IN GREEK INFLAMMATORY BOWEL DISEASE PATIENTS

Konstantinos Karmiris, Anastasios Avgerinos, Aikaterini Tavernaraki, Christos Zeglinas, Pantelis Karatzas, Theodoros Koukouratos, Konstantinos Oikonomou, Athanasios Kostas, Evanthia Zampeli, Vasileios Papadopoulos, Angeliki Theodoropoulou, Dimitrios Polymeros, Giorgos Bamias, Andreas N. Kapsoritakis, Vasiliki Haskoni, Gerass

IS ANTI-PD1-INDUCED COLITIS A DISTINCT HISTOLOGICAL SUBTYPE?

Stratigoula Sakellariou, Ioanna Delladetsima, Giorgos Bamias, Evgenia Papathanasiou, Maria Sotiropoulou, Evanthia Zampeli, Spyridon Michopoulos

MUCOSAL MOLECULAR SIGNATURES DIFFER BETWEEN ULCERATIVE COLITIS PATIENTS WITH OR WITHOUT RESPONSE TO VEDOLIZUMAB THERAPY

Giorgos Bamias, Maria Gazouli, Vasileios Xourafas, Eirini Zacharopoulou, Emmanouela Tsoukali, Nikos Viazis, Gerassimos J. Mantzaris, Michalis Gizis, Maria Tzouvala, Georgios Leonidakis, Evanthia Zampeli, Spyridon Michopoulos, Konstantinos Makris, Georgios Michalopoulos, Georgios Papatheodoridis

Real life data evaluating Helicobacter pylori eradication rates after application of Maastricht V guidelines

Georgios Axiaris, Maria Stoupaki, Vassiliki Gkagkari, Georgios Leonidakis, Evgenia Papathanasiou, Anastasios Karlaftis, Maria Sotiropoulou, Kalliopi Petraki, Beatriz Martinez-Gonzalez, Dionyssios Sgouras, Andreas Mentis, Evanthia Zampeli, Panagiotis Baxevanis, Spyridon Michopoulos

THE NATURAL HISTORY OF COVID-19 IN PATIENTS WITH IBD: A NATIONWIDE STUDY BY THE HELLENIC SOCIETY FOR THE STUDY OF IBD

Dimitrios K. Christodoulou, Georgios Kokkotis, Vasileios Delis, Andreas N. Kapsoritakis, OLGA GIOULEME, Pantelis Karatzas, Konstantinos Karmiris, Anthia Gatopoulou, Chryssostomos Kalantzis, Konstantinos H. Katsanos, Ioannis Papaconstantinou, Spyridon Michopoulos, Polyxeni Kevrekidou, Nicoletta Mathou, Georgios Michalopoulos;;

THE NATURAL HISTORY OF COVID-19 IN VACCINATED INFLAMMATORY BOWEL DISEASE PATIENTS

Nikos Viazis, Ioannis Drygiannakis, Konstantinos Karmiris, Angeliki Theodoropoulou, Evanthia Zampeli, Maria Tzouvala, Giorgos Bamias, Christos Liatsos, Georgios Theocharis, Spyridon Vrakas, Eftychia Tsironi, Nicoletta Mathou, AIKATERINI MANTAKA, Angeliki Christidou, Kanellos Rafail Koustenis, Christos Veretanos, Evgenia Pap

THE VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL FOR CROHN'S DISEASE EFFECTIVELY PREDICTS CLINICAL REMISSION AT 54 WEEKS IN A "REAL WORLD" SETTING

Konstantina Chalakatevaki, Georgios Kokkotis, Evgenia Papathanasiou, Nikolaos Kioulos, Michalis Gizis, Matina Lydia Chatzinikolaou, Ioannis Koutsounas, Spyridon Michopoulos, Evanthia Zampeli, Giorgos Bamias

TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE

Nikos Viazis, Dimitrios K. Christodoulou, OLGA GIOULEME, Angeliki Theodoropoulou, Giorgos Bamias, Evanthia Zampeli, Ioannis Koutroubakis, Maria Tzouvala, Konstantinos Karmiris, Ioanna Mousavere, Konstantinos H. Katsanos, Marios Katsaros, Vasiliki Kitsou, Georgios Axiaris, Spyridon Michopoulos, Kalliopi Foteinogiannopoulou,

Treatment outcomes following administration of vedolizumab in patients with moderate to severe Ulcerative colitis

Giorgos Bamias, Vasileios Xourafas, Emmanouela Tsoukali, Nikos Viazis, Gerassimos J. Mantzaris, Michalis Gizis, Eirini Zacharopoulou, Maria Tzouvala, Georgios Leonidakis, Evanthia Zampeli, Spyridon Michopoulos, Konstantinos Makris, Georgios Michalopoulos, Georgios Papatheodoridis

Item 1 - 10 / 11
1
2